Wang Qunbin, aged 50, is an Executive Director and Co-Chairman of Fosun International.

Mr. Wang is the founder of the Group and has been a director of various companies within the Group since 1994. Mr. Wang was a director of Yuyuan (listed on the Shanghai Stock Exchange) and Henan Lingrui Pharmaceutical Co., Ltd. (listed on the Shanghai Stock Exchange with stock code 600285). He was also the non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange) and Sinopharm (listed on the Hong Kong Stock Exchange). Mr. Wang was awarded "Asia Pacific Outstanding Entrepreneur Awards" by Enterprise Asia and "Best Asian Corporate Director" at the Asian Excellence Recognition Awards by Corporate Governance Asia, etc., and was named one of "China's 50 Top-performing Corporate Leaders" by Harvard Business Review. Mr. Wang received a bachelor's degree in genetic engineering from Fudan University in 1991.